LA JOLLA, Calif., Jan. 22, 2026 /PRNewswire/ – Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of genomics pioneer J. Craig Venter, Ph.D.
DGI is developing the next–generation discovery and diagnostics platform for complex and deadly diseases, making future health outcomes more predictable, measurable, and actionable. DGI plans to employ advanced AI models, along with the latest genomic sequencing technology combined with advanced imaging and health data, to deliver diagnostic insights with higher precision for life science companies, health systems, researchers, and patients.
“At Healthier Capital, we are inspired by the pioneering spirit of J. Craig Venter and the DGI leadership team and are enthusiastic to serve as co-founders in delivering transformative impacts to better preventing, diagnosing, treating and innovating care,” said Healthier Capital partner, Aman Mahajan M.D., Ph.D.
“We believe that DGI’s proprietary, AI-driven approach to combining genomics sequencing with advanced imaging and additional data sources, will transform the way treatments are developed, diseases are diagnosed, and therapies are delivered,” said Healthier Capital founder and managing partner, Amir Dan Rubin.
DGI has been designed as a high-leverage platform from day one, powered by a high-performance partner ecosystem. Through access to the latest sequencing technology from PacBio and Oxford Nanopore, unique computing infrastructure, and proprietary genomics and imaging data from the J. Craig Venter Institute (JCVI, a not-for-profit research institute), and select collaborators, DGI is launching with unusually deep data assets and immediate technical advantages. The company is exploring strategic partnerships across leading academic medical centers, AI organizations, and life sciences companies.
DGI is building its own sequencing center in a new San Diego waterfront location and will seek CLIA certification (Clinical Laboratory Improvement Amendments—the certification needed for laboratories to provide clinical data to patients) to provide AI-enhanced, next generation clinical grade sequencing.
DGI has been formed using know-how and expertise from JCVI, and is helmed by Dr. Venter, along with multimodal imaging expert Anders Dale, Ph.D., and computational sciences expert Gene Myers, Ph.D.